Applied DNA Sciences (APDN) Misses Q2 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/3/2026
- S&P 500, Nasdaq rise as tech stocks gain ahead of midterm results
- Apple shares slip amid guidance for tightening margins, slowing services growth
- Rising shorts cool U.S. large-cap positioning, cutting liquidation risk: Citi
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
Tweet
Share
E-mailGet Alerts APDN Hot Sheet
Price: $5.62 --0%
Financial Fact:
Net loss before provision for income taxes: -2.42M
Today's EPS Names:
INM, TRI, CRVL, More
Financial Fact:
Net loss before provision for income taxes: -2.42M
Today's EPS Names:
INM, TRI, CRVL, More
Join SI Premium – FREE
Applied DNA Sciences (NASDAQ: APDN) reported Q2 EPS of ($0.14), $0.03 worse than the analyst estimate of ($0.11).
For earnings history and earnings-related data on Applied DNA Sciences (APDN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apple's 'unprecedented' memory warning adds fuel to wobbly Micron, SK hynix trade
- Citi expects ’continued memory undersupply’ in 2027
- Expeditors Int'l (EXPD) Tops Q3 EPS by 45c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
